Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin J Burwitz

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Cell Host & Microbe|August 18, 2022
Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate speciesDaniel Malouli, Roxanne M Gilbride, Helen L Wu, et al.
JCI Insight|July 15, 2025
Prophylactic and therapeutic neutralizing monoclonal antibody treatment prevents lethal yellow fever infectionLauren N Rust, Michael J Ricciardi, Savannah S Lutz, et al.
Science Translational Medicine|March 29, 2023
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infectionMichael J Ricciardi, Lauren N Rust, Nuria Pedreño-Lopez, et al.
Immunity|May 26, 2023
Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaquesHelen L Wu, Kathleen Busman-Sahay, Whitney C Weber, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Cell Host & Microbe|August 18, 2022
Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate speciesDaniel Malouli, Roxanne M Gilbride, Helen L Wu, et al.
JCI Insight|July 15, 2025
Prophylactic and therapeutic neutralizing monoclonal antibody treatment prevents lethal yellow fever infectionLauren N Rust, Michael J Ricciardi, Savannah S Lutz, et al.
Science Translational Medicine|March 29, 2023
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infectionMichael J Ricciardi, Lauren N Rust, Nuria Pedreño-Lopez, et al.
Immunity|May 26, 2023
Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaquesHelen L Wu, Kathleen Busman-Sahay, Whitney C Weber, et al.
Pageof 7